Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

8. Bracketology Part 2

8. Bracketology Part 2

FromRheumMadness Podcast


8. Bracketology Part 2

FromRheumMadness Podcast

ratings:
Length:
33 minutes
Released:
Mar 10, 2021
Format:
Podcast episode

Description

In this episode David Leverenz, Aki Udupa, Didem Saygin, and Guy Katz discuss the second half of the RheumMadness bracket.  The first half was covered in the previous episode (Bracketology Part 1).  You can learn more about RheumMadness here: https://sites.duke.edu/rheummadness/References for topics discussed in this episodeSEMIRA Study in RA: Burmester et al. Lancet.2020;396(10246):267-76 (pubmed link)Harms of Short Term Steroids: Yao et al. Ann Intern Med.2020;173(5):325-30 (pubmed link)UK FROST Trial for Frozen Shoulder: Rangan et al. Lancet.2020;396(10256):977-89 (pubmed link)PT vs. GC Injection for Knee Osteoarthritis: Deyle et al. NEJM.2020;382(15):1420-29 (pubmed link)PRIME Cells in RA: Orange et al. NEJM.2020;383(3):218-28 (pubmed link)Synovial B Cells and Therapy Response in RA: Humby et al. Lancet.2021;397(10271):305-17 (pubmed link)FAST Study in Gout: Mackenzie et al. Lancet.2020;396(10264):1745-57 (pubmed link)ACR 2020 Gout Guidelines: Fitzgerald et al. AC&R.2020;72(6):744-60 (pubmed link)Intro and Outro music:Cheery Monday by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3495-cheery-mondayLicense: http://creativecommons.org/licenses/by/4.0/
Released:
Mar 10, 2021
Format:
Podcast episode

Titles in the series (32)

The RheumMadness podcast is part of a rheumatology learning initiative sponsored by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award. Dr. Leverenz has also received grant funding from Pfizer for quality improvement work unrelated to RheumMadness.